Skip to main content

Body Dysmorphic Disorders clinical trials at UC Health

2 in progress, 1 open to eligible people

Showing trials for
  • Perceptual Abnormalities and Their Malleability in BDD

    open to eligible people ages 18-40

    A core symptom of body dysmorphic disorder (BDD) is perceptual distortions for appearance, which contributes to poor insight and delusionality, limits engagement in treatment, and puts individuals at risk for relapse. Results from this study will provide a comprehensive mechanistic model of brain, behavioral, and emotional contributors to abnormal perceptual processing, as well as how malleable it is with visual modulation techniques. This will lay the groundwork for next-step translational perceptual retraining approaches.

    at UCLA

  • Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder

    Sorry, not yet accepting patients

    In this pilot study 12 adult outpatients with body dysmorphic disorder that has not responded to at least one adequate trial of a serotonin reuptake inhibitor will be treated openly with a single oral dose of psilocybin. Followup visits to monitor safety and clinical outcome will be conducted over a 3 month period.

    at UCLA

Last updated: